InsidersTradesSigma
Follow the Thyrocare Technologies Limited stock price and the full directors' dealings record of the company, a listed issuer based in India. Shares trade on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Technology sector, Thyrocare Technologies Limited has published 80 public disclosures. Market capitalisation: €89.8bn. The latest transaction was reported on 31 March 2026 (Purchase). Among the most active insiders: Rahul Guha. The full history is accessible without an account.
80
Insider Decl.
n/a
Thresholds
€551,246
44 ops.
Buy Volume
€589m
28 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Thyrocare Technologies Limited Strong Buy (bullish), based on 5 analysts. Average price target: ₹649.00.
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,780 of 29,052 companies
61.4
score / 100
Value35
Quality88
FCF yld2.1%
Earn yld1.8%
EV/EBITDA32.9x
ROE29%
Gross mgn73%
Net mgn20%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 March 2026
Declarations80 total
2,500 shares@ ₹350.500.0000% mcap22.4% of flowEquity SharesSEBI:3e1142e74802567ec311f59c869e0af84336d6fa
1,000 shares@ ₹358.200.0000% mcap100.0% of flowEquity SharesSEBI:05284eb6d277ed4aa857b77c06622a98dbcab859
300 shares@ ₹358.700.0000% mcap27.9% of flowEquity SharesSEBI:dc7a42eb8f2db33669a5bf36c164f29e7dc0fb87
10,000 shares@ ₹365.850.0001% mcap35.5% of flowEquity SharesSEBI:5a2184d7017a47b36ce791d29786e1441ab982f1
400 shares@ ₹364.160.0000% mcap10.5% of flowEquity SharesSEBI:7db89935b37a25bc8bdd330a5eb3a2d4602f9e4a
100 shares@ ₹361.150.0000% mcap8.2% of flowEquity SharesSEBI:6a6cf2f1151285413e93fbb8e97e46ee81a2d84e
1,125 shares@ ₹360.14760.0000% mcap91.8% of flowEquity SharesSEBI:df33b4bc2bc021296fe781b4203b45e7d1e8492c
2,900 shares@ ₹353.760.0000% mcap100.0% of flowEquity SharesSEBI:484678b4606ca303df9ca7526f05859f3b3151c6
49 shares@ ₹367.65310.0000% mcap25.6% of flowEquity SharesSEBI:cdf40de98f310f3afb4560819fd43829211b3776
150 shares@ ₹377.000.0000% mcap20.5% of flowEquity SharesSEBI:4130d386bb6790d1a100f55bb89b8600b79c1c8b
100 shares@ ₹382.000.0000% mcap19.9% of flowEquity SharesSEBI:7c116ada8ab5533b1e1548d31170b49b295a7823
400 shares@ ₹382.360.0000% mcap10.9% of flowEquity SharesSEBI:bf126566b71a5d133a51436d50230ee0c4b56a6b
100 shares@ ₹385.000.0000% mcap20.2% of flowEquity SharesSEBI:fa6c6f10fb75234353f205305916a510394e0393
1,000 shares@ ₹398.49100.0% of flowEquity SharesSEBI:52c3d80c04f950971ccf5a13c7d4ec9c8d5db456
500 shares@ ₹420.6415.1% of flowEquity SharesSEBI:af01b48dd0990cb6c8b1dfc511076231b7da0866
5,500 shares@ ₹420.076100.0% of flowEquity SharesSEBI:e7c2a5cd6bf6ecb4273a39756e195dd1a348e067
130 shares@ ₹404.5074.4% of flowEquity SharesSEBI:8784afc392ada1876c5111bbeeecc04a80266545
5 shares@ ₹381.40100.0% of flowEquity SharesSEBI:155da2967c2fa6e2c505942329ec977aecf7c135
2,000 shares@ ₹376.9087.3% of flowEquity SharesSEBI:f20b9c19c07337617efbe4b51727b14094d3f6df
200 shares@ ₹397.45100.0% of flowEquity SharesSEBI:84aea619dc7e9d84208adee28fa16893188e6270
80 shares@ ₹384.5016.2% of flowEquity SharesSEBI:744ae0f5290e7fad992f22bc922adc95157d74e1
215 shares@ ₹389.372143.8% of flowEquity SharesSEBI:b2fcdb3df59023cc443be827f5b4fa758edb5fd8
1,000 shares@ ₹387.5012.8% of flowEquity SharesSEBI:c6030034d9ccf72064d91e536ef302dbdd58451d
2,000 shares@ ₹94.3691.8% of flowEquity SharesSEBI:7d1ca82a843c780f0c515955bb4261e5a076ca02
4,500 shares@ ₹390.0057.1% of flowEquity SharesSEBI:4d66ab4799f2446a3401a5f208847f48d793f788
25 of 80 declarations
About Thyrocare Technologies Limited
Thyrocare Technologies Limited is a company specializing in medical diagnostic services and laboratory testing. It offers a wide range of health tests, including hormonal tests and screening tests.